Analysis of Nephrolithiasis Treatment in Highest Reference Hospital—Occurrence of Acromegaly in the Study Group
Background: Urolithiasis is one of the most common diseases of the urinary system, the incidence of which is assumed to be up to 100,000 cases per million (10% of the population). The cause of it is dysregulation of renal urine excretion. Acromegaly is a very rare endocrine disorder that causes a so...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-06-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/12/12/3879 |
| _version_ | 1797594168760991744 |
|---|---|
| author | Tomasz Ząbkowski Adam Daniel Durma Agnieszka Grabińska Łukasz Michalczyk Marek Saracyn |
| author_facet | Tomasz Ząbkowski Adam Daniel Durma Agnieszka Grabińska Łukasz Michalczyk Marek Saracyn |
| author_sort | Tomasz Ząbkowski |
| collection | DOAJ |
| description | Background: Urolithiasis is one of the most common diseases of the urinary system, the incidence of which is assumed to be up to 100,000 cases per million (10% of the population). The cause of it is dysregulation of renal urine excretion. Acromegaly is a very rare endocrine disorder that causes a somatotropic pituitary adenoma producing higher amounts of growth hormone. It occurs approximately in 80 cases per million (about 0.008% of the population). One of the acromegaly complications may be urolithiasis. Methods: Clinical and laboratory results of 2289 patients hospitalized for nephrolithiasis in the highest reference hospital were retrospectively analyzed, distinguishing a subgroup of patients with acromegaly. Statistical analysis was performed to compare the prevalence of the disease in the analyzed subgroup with the epidemiological results available in up-to-date literature. Results: The distribution of nephrolithiasis treatment was definitely in favor of non-invasive and minimally invasive treatment. The methods used were as follows: ESWL (61.82%), USRL (30.62%), RIRS (4.15%), PCNL (3.1%), and pyelolithotomy (0.31%). Such a distribution limited the potential complications of the procedures while maintaining the high effectiveness of the treatment. Among two thousand two hundred and eighty-nine patients with urolithiasis, two were diagnosed with acromegaly before the nephrological and urological treatment, and seven were diagnosed de novo. Patients with acromegaly required a higher percentage of open surgeries (including nephrectomy) and also had a higher rate of kidney stones recurrence. The concentration of IGF-1 in patients with newly diagnosed acromegaly was similar to those treated with somatostatin analogs (SSA) due to incomplete transsphenoidal pituitary surgery. Conclusions: In the population of patients with urolithiasis requiring hospitalization and interventional treatment compared to the general population, the prevalence of acromegaly was almost 50-fold higher (<i>p</i> = 0.025). Acromegaly itself increases the risk of urolithiasis. |
| first_indexed | 2024-03-11T02:19:47Z |
| format | Article |
| id | doaj.art-cdbea663b7174d6081737456243b1910 |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-11T02:19:47Z |
| publishDate | 2023-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-cdbea663b7174d6081737456243b19102023-11-18T10:57:56ZengMDPI AGJournal of Clinical Medicine2077-03832023-06-011212387910.3390/jcm12123879Analysis of Nephrolithiasis Treatment in Highest Reference Hospital—Occurrence of Acromegaly in the Study GroupTomasz Ząbkowski0Adam Daniel Durma1Agnieszka Grabińska2Łukasz Michalczyk3Marek Saracyn4Department of Urology, Military Institute of Medicine—National Research Institute, 02-637 Warsaw, PolandDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine—National Research Institute, 02-637 Warsaw, PolandDepartment of Urology, Military Institute of Medicine—National Research Institute, 02-637 Warsaw, PolandUrology Department, District Hospital, 26-900 Kozienice, PolandDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine—National Research Institute, 02-637 Warsaw, PolandBackground: Urolithiasis is one of the most common diseases of the urinary system, the incidence of which is assumed to be up to 100,000 cases per million (10% of the population). The cause of it is dysregulation of renal urine excretion. Acromegaly is a very rare endocrine disorder that causes a somatotropic pituitary adenoma producing higher amounts of growth hormone. It occurs approximately in 80 cases per million (about 0.008% of the population). One of the acromegaly complications may be urolithiasis. Methods: Clinical and laboratory results of 2289 patients hospitalized for nephrolithiasis in the highest reference hospital were retrospectively analyzed, distinguishing a subgroup of patients with acromegaly. Statistical analysis was performed to compare the prevalence of the disease in the analyzed subgroup with the epidemiological results available in up-to-date literature. Results: The distribution of nephrolithiasis treatment was definitely in favor of non-invasive and minimally invasive treatment. The methods used were as follows: ESWL (61.82%), USRL (30.62%), RIRS (4.15%), PCNL (3.1%), and pyelolithotomy (0.31%). Such a distribution limited the potential complications of the procedures while maintaining the high effectiveness of the treatment. Among two thousand two hundred and eighty-nine patients with urolithiasis, two were diagnosed with acromegaly before the nephrological and urological treatment, and seven were diagnosed de novo. Patients with acromegaly required a higher percentage of open surgeries (including nephrectomy) and also had a higher rate of kidney stones recurrence. The concentration of IGF-1 in patients with newly diagnosed acromegaly was similar to those treated with somatostatin analogs (SSA) due to incomplete transsphenoidal pituitary surgery. Conclusions: In the population of patients with urolithiasis requiring hospitalization and interventional treatment compared to the general population, the prevalence of acromegaly was almost 50-fold higher (<i>p</i> = 0.025). Acromegaly itself increases the risk of urolithiasis.https://www.mdpi.com/2077-0383/12/12/3879acromegalyurolithiasisURSLRIRSPCNLESWL |
| spellingShingle | Tomasz Ząbkowski Adam Daniel Durma Agnieszka Grabińska Łukasz Michalczyk Marek Saracyn Analysis of Nephrolithiasis Treatment in Highest Reference Hospital—Occurrence of Acromegaly in the Study Group Journal of Clinical Medicine acromegaly urolithiasis URSL RIRS PCNL ESWL |
| title | Analysis of Nephrolithiasis Treatment in Highest Reference Hospital—Occurrence of Acromegaly in the Study Group |
| title_full | Analysis of Nephrolithiasis Treatment in Highest Reference Hospital—Occurrence of Acromegaly in the Study Group |
| title_fullStr | Analysis of Nephrolithiasis Treatment in Highest Reference Hospital—Occurrence of Acromegaly in the Study Group |
| title_full_unstemmed | Analysis of Nephrolithiasis Treatment in Highest Reference Hospital—Occurrence of Acromegaly in the Study Group |
| title_short | Analysis of Nephrolithiasis Treatment in Highest Reference Hospital—Occurrence of Acromegaly in the Study Group |
| title_sort | analysis of nephrolithiasis treatment in highest reference hospital occurrence of acromegaly in the study group |
| topic | acromegaly urolithiasis URSL RIRS PCNL ESWL |
| url | https://www.mdpi.com/2077-0383/12/12/3879 |
| work_keys_str_mv | AT tomaszzabkowski analysisofnephrolithiasistreatmentinhighestreferencehospitaloccurrenceofacromegalyinthestudygroup AT adamdanieldurma analysisofnephrolithiasistreatmentinhighestreferencehospitaloccurrenceofacromegalyinthestudygroup AT agnieszkagrabinska analysisofnephrolithiasistreatmentinhighestreferencehospitaloccurrenceofacromegalyinthestudygroup AT łukaszmichalczyk analysisofnephrolithiasistreatmentinhighestreferencehospitaloccurrenceofacromegalyinthestudygroup AT mareksaracyn analysisofnephrolithiasistreatmentinhighestreferencehospitaloccurrenceofacromegalyinthestudygroup |